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DISCUSSION
Dr Daniel B. Walsh (Lebanon, NY). This paper’s critical
finding is that vein patch angioplasty and vein graft interposition of
mid-vein graft stenoses in situ bypasses achieve similar 5-year
patency results. In a smaller group of excised grafts, the interposi-
tion graft did not fair quite as well.
Are these truly comparable groups? The authors readily admit
that this was not a randomized trial. The individual surgeon
determined the therapeutic strategy. Was it clear that both options
were possible in all these patients, or were there other determining
factors such as vein quality or availability? Clearly, the group with
excised veins had to be different, as these patients did not have vein
available for in situ bypass at the original procedure. Is this the
reason the interposition group did not fair as well? Can the authors
comment on the impact of this potential selection bias on their
results. Since their study, have they changed their practice in any
way when dealing with mid-graft stenoses?
Dr Paul B. Kreienberg. Thank you very much for your
comments. I agree we are limited because this is a retrospective
review and is not randomized. And I think, certainly, the excised
vein group is somewhat disadvantaged as compared to the in situ
group in terms of the quality of the vein.
If you look at the overall revision rate for the different types of
bypasses, it is higher in excised veins. When you break out the
revisions for the in situs that were just fistula ligation or simple
valve lysis, you see the difference. Revision rates on the splices and
the excised veins are actually a little bit higher, and so there is some
selection bias.
Now, the options for repair, both options may not be available
in all patients and that’s where part of the selection problem comes
in. Basically, our algorithm for repairing vein lesions is to do
primary repair first if the lesions are short enough and enough vein
can bemobilized to do that. Next would be a patch, and then to do
the interposition. Which one of the latter two you choose really
depends on the available conduit.
Now, although it wasn’t statistically significant, the interposi-
tions did have a somewhat poorer patency. I’ll need to explore this
a little deeper and go back and review the patients who had the
excised veins.
We know if bypasses need to be revised earlier in their lifespan,
they’re more likely to require more revisions to maintain patency
and they don’t tend to perform as well. We did take out all the ones
that were revised at less than a month after their initial procedure.
Despite this we still didn’t see any difference in that data.
I just want to touch on, a little bit, the genesis of this paper.
Our group gets together every morning. We stand at the angio-
gram viewer with the fellows, all the surgeons are there, and put up
the cases of the day. And every once in a while a case will come up
where there is a lesion that we’re going to have to revise, and
there’s four of us that say we should fix that with a patch and four
of us say we should fix this with an interposition.
I know when I first started in practice, I was kind of loathe to
put a patch over this rubbery, hypertrophied, eccentric lesion and
say it is going to function as well. And I think by going back and
looking at our data, I feel, I have a little more peace of mind when
I place a patch over that area.
Dr Ronald L. Nath (Stoneham, MA). We tend to use bovine
pericardium as our conduit of choice either for veins grafts, other
types of grafts, or arteries that need patching. I wonder if you have
had experience with bovine pericardium and therefore why you
have chosen to harvest a piece of vein primarily rather than saving
vein for conduit use.
A second question I would like to ask may not strictly relate to
the paper. We have always been taught that use of spliced vein for
bypass conduit has a much lower patency rate, as you yourself have
shown here, because of the number of anastomoses required, that
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the more anastomosis the shorter becomes the life expectancy of
that particular conduit. If that is true, then one would think that a
patch would fare better than a spliced vein bypass repair. Does that
logic follow? Have you been able to analyze that subset?
Dr Kreienberg. Well, to answer the last question first, Dr
Chang from our group published a paper on spliced veins and
found that the patency really didn’t change until you got beyond
four splices. So with one interposition in there, it is not going to
make a difference.
As to the bovine pericardial patch, my only experience with
that is doing patches for inflow lesions, and I have not used it on
the conduit itself.
Usually, if you are performing a patch, you can find a segment
of vein somewhere. And basically, the order we go through for
looking for vein is probably to use residual greater from the
ipsilateral leg, see if there is residual greater from the contralateral
leg, then we use lesser, or arm vein, in that order. Usually for a vein
patch, you can find even a branch that you can use that will be long
enough to perform the patch, such as the descending lateral branch
of the saphenous vein.
Dr Steven P. Rivers (Bronx, NY). I’d also like to explore a
little bit where you are getting the source of your conduits,
specifically for the interposition grafts. Are they primarily con-
tralateral greater saphenous, ipsilateral lesser saphenous, cephalic?
Do you have enough of each that you can say with any confidence
that the vein from one location functions better than a vein from
another location?
If you have a failing bypass graft in one leg and a patient with
contralateral disease, I mean, I guess the real question is should we
use the ipsilateral lesser saphenous and save the other side, or
should we take the best vein, which is the greater saphenous, from
the other leg?
Dr Kreienberg. The choice becomes important. I don’t have
the data for exactly what distribution of the interpositions were in
terms of using arm vein, lesser saphenous vein or greater saphenous
vein. Obviously, you do have to keep in mind when you are
performing that, you want to put in the best piece you can but
preserve further options down the road.
Dr William R. Flinn (Baltimore, MD). Dr Kreinenberg, do
you ever not operate on these? Do you ever do angioplasties on any
of them? Is there any indication for this or other endovascular
interventions for vein graft stenoses?
Dr Kreienberg. There are some patients that—and I have a
couple patients that I follow—have basically got increased
velocities in a segment due to comorbidities. I followed some of
them and let them drift a little higher before I would operate on
them.
In the reverse veins, and in the spliced veins, we tunnel
everything subcutaneously. So the access to these is relatively easy.
So even in a patient who has maybe severe comorbid problems, this
is a procedure that can be done under local anesthesia. And so there
are very few patients who develop a lesion that we won’t operate
on.
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